世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
肺がん診断とスクリーニングの世界市場レポート 2023年以下を含む：1) 製品別2)検査別：バイオマーカー検査、画像検査、生検、血液検査3)がんタイプ別：非小細胞肺がん、小細胞肺がん4)エンドユーザー別：病院、独立系肺がん、小細胞肺がん非小細胞肺がん、小細胞肺がん4) エンドユーザー別：病院、独立診断研究所、画像診断センター、がん研究機関5) カバー：ファイザー株式会社、F：ファイザー；F. ホフマン・ラ・ロシュ；ブリストル・マイヤーズ スクイブ；サーモフィッシャーサイエンティフィック；アストラゼネカ PlcLung Cancer Diagnostic And Screening Global Market Report 2023Including: 1) By Product: Instruments; Consumables And Accessories2) By Test: Biomarkers Tests; Imaging Test; Biopsy; Blood Test3) By Cancer Type: Non-Small Cell Lung Cancer; Small Cell Lung Cancer4) By End User: Hospital; Independent Diagnostic Laboratories; Diagnostic Imaging Centers; Cancer Research InstitutessCovering: Pfizer Inc.; F. Hoffmann-La Roche AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; AstraZeneca Plc The Business Research Companyの肺癌診断とスクリーニングの世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは、力強... もっと見る
サマリーThe Business Research Companyの肺癌診断とスクリーニングの世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは、力強い成長を遂げている肺癌診断とスクリーニング市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 肺がん診断とスクリーニングの最大かつ最速の成長市場はどこか？この市場は経済全体、人口動態、その他の類似市場とどのように関連しているのか？今後どのような力が市場を形成していくのか？ビジネスリサーチ社の肺がん診断とスクリーニング世界市場レポートでは、これらすべての質問とその他多くの質問にお答えします。 当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、動向、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場：1) 製品別機器；消耗品および付属品 2) 検査別：バイオマーカー検査、画像検査、生検、血液検査、その他検査 3) 癌タイプ別：非小細胞肺癌非小細胞肺がん；小細胞肺がん 4) エンドユーザー別：病院、独立診断研究所、画像診断センター、がん研究機関、その他のエンドユーザー 言及された企業ファイザー、F.ホフマン・ラ・ロシュ、ブリストル・マイヤーズ スクイブ、サーモフィッシャーサイエンティフィック、アストラゼネカ 国オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列：過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Lung Cancer Diagnostic And Screening Market Characteristics 3. Lung Cancer Diagnostic And Screening Market Trends And Strategies 4. Lung Cancer Diagnostic And Screening Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Lung Cancer Diagnostic And Screening Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Lung Cancer Diagnostic And Screening Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Lung Cancer Diagnostic And Screening Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Lung Cancer Diagnostic And Screening Market Segmentation 6.1. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Instruments Consumables And Accessories 6.2. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Biomarkers Tests Imaging Test Biopsy Blood Test Other Tests 6.3. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Non-Small Cell Lung Cancer Small Cell Lung Cancer 6.4. Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Independent Diagnostic Laboratories Diagnostic Imaging Centers Cancer Research Institutes Other End-Users 7. Lung Cancer Diagnostic And Screening Market Regional And Country Analysis 7.1. Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Lung Cancer Diagnostic And Screening Market 8.1. Asia-Pacific Lung Cancer Diagnostic And Screening Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Lung Cancer Diagnostic And Screening Market 9.1. China Lung Cancer Diagnostic And Screening Market Overview 9.2. China Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Lung Cancer Diagnostic And Screening Market 10.1. India Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Lung Cancer Diagnostic And Screening Market 11.1. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Lung Cancer Diagnostic And Screening Market 12.1. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Lung Cancer Diagnostic And Screening Market 13.1. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Lung Cancer Diagnostic And Screening Market 14.1. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Lung Cancer Diagnostic And Screening Market 15.1. Western Europe Lung Cancer Diagnostic And Screening Market Overview 15.2. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Lung Cancer Diagnostic And Screening Market 16.1. UK Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Lung Cancer Diagnostic And Screening Market 17.1. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Lung Cancer Diagnostic And Screening Market 18.1. France Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Lung Cancer Diagnostic And Screening Market 19.1. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Lung Cancer Diagnostic And Screening Market 20.1. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Lung Cancer Diagnostic And Screening Market 21.1. Eastern Europe Lung Cancer Diagnostic And Screening Market Overview 21.2. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Lung Cancer Diagnostic And Screening Market 22.1. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Lung Cancer Diagnostic And Screening Market 23.1. North America Lung Cancer Diagnostic And Screening Market Overview 23.2. North America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Lung Cancer Diagnostic And Screening Market 24.1. USA Lung Cancer Diagnostic And Screening Market Overview 24.2. USA Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Lung Cancer Diagnostic And Screening Market 25.1. Canada Lung Cancer Diagnostic And Screening Market Overview 25.2. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Lung Cancer Diagnostic And Screening Market 26.1. South America Lung Cancer Diagnostic And Screening Market Overview 26.2. South America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Lung Cancer Diagnostic And Screening Market 27.1. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Lung Cancer Diagnostic And Screening Market 28.1. Middle East Lung Cancer Diagnostic And Screening Market Overview 28.2. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Lung Cancer Diagnostic And Screening Market 29.1. Africa Lung Cancer Diagnostic And Screening Market Overview 29.2. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Lung Cancer Diagnostic And Screening Market Competitive Landscape And Company Profiles 30.1. Lung Cancer Diagnostic And Screening Market Competitive Landscape 30.2. Lung Cancer Diagnostic And Screening Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. F. Hoffmann-La Roche AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Bristol-Myers Squibb Company 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Thermo Fisher Scientific Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. AstraZeneca Plc 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Lung Cancer Diagnostic And Screening Market Other Major And Innovative Companies 31.1. Abbott Laboratories Inc. 31.2. Medtronic Plc. 31.3. Danaher Corporation 31.4. Siemens Healthcare GmbH 31.5. FUJIFILM Corporation 31.6. Koninklijke Philips N.V. 31.7. GE Healthcare Bio Sciences AB 31.8. Quest Diagnostics Incorporated 31.9. Agilent Technologies Inc. 31.10. Illumina Inc. 31.11. Qiagen Inc. 31.12. Myriad Genetic Laboratories Inc. 31.13. NeoGenomics Laboratories Inc. 31.14. Canon Medical Systems Corporation 31.15. Eon Health Inc. 32. Global Lung Cancer Diagnostic And Screening Market Competitive Benchmarking 33. Global Lung Cancer Diagnostic And Screening Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Lung Cancer Diagnostic And Screening Market 35. Lung Cancer Diagnostic And Screening Market Future Outlook and Potential Analysis 35.1 Lung Cancer Diagnostic And Screening Market In 2027 - Countries Offering Most New Opportunities 35.2 Lung Cancer Diagnostic And Screening Market In 2027 - Segments Offering Most New Opportunities 35.3 Lung Cancer Diagnostic And Screening Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryLung Cancer Diagnostic And Screening Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Lung Cancer Diagnostic And Screening Market Characteristics 3. Lung Cancer Diagnostic And Screening Market Trends And Strategies 4. Lung Cancer Diagnostic And Screening Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Lung Cancer Diagnostic And Screening Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Lung Cancer Diagnostic And Screening Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Lung Cancer Diagnostic And Screening Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Lung Cancer Diagnostic And Screening Market Segmentation 6.1. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Instruments Consumables And Accessories 6.2. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Biomarkers Tests Imaging Test Biopsy Blood Test Other Tests 6.3. Global Lung Cancer Diagnostic And Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Non-Small Cell Lung Cancer Small Cell Lung Cancer 6.4. Global Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Independent Diagnostic Laboratories Diagnostic Imaging Centers Cancer Research Institutes Other End-Users 7. Lung Cancer Diagnostic And Screening Market Regional And Country Analysis 7.1. Global Lung Cancer Diagnostic And Screening Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Lung Cancer Diagnostic And Screening Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Lung Cancer Diagnostic And Screening Market 8.1. Asia-Pacific Lung Cancer Diagnostic And Screening Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Lung Cancer Diagnostic And Screening Market 9.1. China Lung Cancer Diagnostic And Screening Market Overview 9.2. China Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Lung Cancer Diagnostic And Screening Market 10.1. India Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Lung Cancer Diagnostic And Screening Market 11.1. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Lung Cancer Diagnostic And Screening Market 12.1. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Lung Cancer Diagnostic And Screening Market 13.1. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Lung Cancer Diagnostic And Screening Market 14.1. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Lung Cancer Diagnostic And Screening Market 15.1. Western Europe Lung Cancer Diagnostic And Screening Market Overview 15.2. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Lung Cancer Diagnostic And Screening Market 16.1. UK Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Lung Cancer Diagnostic And Screening Market 17.1. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Lung Cancer Diagnostic And Screening Market 18.1. France Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Lung Cancer Diagnostic And Screening Market 19.1. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Lung Cancer Diagnostic And Screening Market 20.1. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Lung Cancer Diagnostic And Screening Market 21.1. Eastern Europe Lung Cancer Diagnostic And Screening Market Overview 21.2. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Lung Cancer Diagnostic And Screening Market 22.1. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Lung Cancer Diagnostic And Screening Market 23.1. North America Lung Cancer Diagnostic And Screening Market Overview 23.2. North America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Lung Cancer Diagnostic And Screening Market 24.1. USA Lung Cancer Diagnostic And Screening Market Overview 24.2. USA Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Lung Cancer Diagnostic And Screening Market 25.1. Canada Lung Cancer Diagnostic And Screening Market Overview 25.2. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Lung Cancer Diagnostic And Screening Market 26.1. South America Lung Cancer Diagnostic And Screening Market Overview 26.2. South America Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Lung Cancer Diagnostic And Screening Market 27.1. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Lung Cancer Diagnostic And Screening Market 28.1. Middle East Lung Cancer Diagnostic And Screening Market Overview 28.2. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Lung Cancer Diagnostic And Screening Market 29.1. Africa Lung Cancer Diagnostic And Screening Market Overview 29.2. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Lung Cancer Diagnostic And Screening Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Lung Cancer Diagnostic And Screening Market Competitive Landscape And Company Profiles 30.1. Lung Cancer Diagnostic And Screening Market Competitive Landscape 30.2. Lung Cancer Diagnostic And Screening Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. F. Hoffmann-La Roche AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Bristol-Myers Squibb Company 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Thermo Fisher Scientific Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. AstraZeneca Plc 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Lung Cancer Diagnostic And Screening Market Other Major And Innovative Companies 31.1. Abbott Laboratories Inc. 31.2. Medtronic Plc. 31.3. Danaher Corporation 31.4. Siemens Healthcare GmbH 31.5. FUJIFILM Corporation 31.6. Koninklijke Philips N.V. 31.7. GE Healthcare Bio Sciences AB 31.8. Quest Diagnostics Incorporated 31.9. Agilent Technologies Inc. 31.10. Illumina Inc. 31.11. Qiagen Inc. 31.12. Myriad Genetic Laboratories Inc. 31.13. NeoGenomics Laboratories Inc. 31.14. Canon Medical Systems Corporation 31.15. Eon Health Inc. 32. Global Lung Cancer Diagnostic And Screening Market Competitive Benchmarking 33. Global Lung Cancer Diagnostic And Screening Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Lung Cancer Diagnostic And Screening Market 35. Lung Cancer Diagnostic And Screening Market Future Outlook and Potential Analysis 35.1 Lung Cancer Diagnostic And Screening Market In 2027 - Countries Offering Most New Opportunities 35.2 Lung Cancer Diagnostic And Screening Market In 2027 - Segments Offering Most New Opportunities 35.3 Lung Cancer Diagnostic And Screening Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート
本レポートと同じKEY WORD（cancer）の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |
